HU172964B - Sposob poluchenija n-aril-n-/1-l-4-piperidinil/-aril-acetamidov - Google Patents

Sposob poluchenija n-aril-n-/1-l-4-piperidinil/-aril-acetamidov

Info

Publication number
HU172964B
HU172964B HU76JA00000767A HUJA000767A HU172964B HU 172964 B HU172964 B HU 172964B HU 76JA00000767 A HU76JA00000767 A HU 76JA00000767A HU JA000767 A HUJA000767 A HU JA000767A HU 172964 B HU172964 B HU 172964B
Authority
HU
Hungary
Prior art keywords
aril
poluchenija
acetamidov
piperidinil
sposob
Prior art date
Application number
HU76JA00000767A
Other languages
English (en)
Hungarian (hu)
Inventor
Stefan Sanczuk
Hubert K F Hermans
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HU172964B publication Critical patent/HU172964B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU76JA00000767A 1975-09-23 1976-09-22 Sposob poluchenija n-aril-n-/1-l-4-piperidinil/-aril-acetamidov HU172964B (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61513175A 1975-09-23 1975-09-23
US71375676A 1976-08-12 1976-08-12

Publications (1)

Publication Number Publication Date
HU172964B true HU172964B (hu) 1979-01-28

Family

ID=27087421

Family Applications (1)

Application Number Title Priority Date Filing Date
HU76JA00000767A HU172964B (hu) 1975-09-23 1976-09-22 Sposob poluchenija n-aril-n-/1-l-4-piperidinil/-aril-acetamidov

Country Status (29)

Country Link
JP (1) JPS6016417B2 (ref)
AT (1) AT363935B (ref)
AU (1) AU510029B2 (ref)
BG (1) BG27543A3 (ref)
CA (1) CA1068271A (ref)
CH (1) CH628623A5 (ref)
CS (1) CS222663B2 (ref)
DE (1) DE2642856A1 (ref)
DK (1) DK150478C (ref)
ES (1) ES451768A1 (ref)
FI (1) FI61482C (ref)
FR (1) FR2325377A1 (ref)
GB (1) GB1539473A (ref)
GR (1) GR58469B (ref)
HU (1) HU172964B (ref)
IE (1) IE43802B1 (ref)
IL (1) IL50522A (ref)
IT (1) IT1073893B (ref)
LU (1) LU75837A1 (ref)
NL (1) NL187267C (ref)
NO (1) NO147672C (ref)
NZ (1) NZ181972A (ref)
PH (1) PH12497A (ref)
PL (2) PL192578A1 (ref)
PT (1) PT65631B (ref)
RO (1) RO70079A (ref)
SE (1) SE427839B (ref)
SU (1) SU747424A3 (ref)
YU (1) YU39973B (ref)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA765684B (en) * 1975-09-23 1978-04-26 Janssen Pharmaceutica Nv Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPS62260786A (ja) * 1986-05-08 1987-11-13 株式会社ヘキトク 燻瓦の製造ラインにおける焼成工程後の表面仕上げ装置
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
JO2642B1 (en) 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
RS52518B (sr) 2007-04-23 2013-04-30 Janssen Pharmaceutica N.V. Derivati 4-alkoksipiridazina kao brzo disocirajući dopamin 2 receptorski antagonisti
CN101663291A (zh) * 2007-04-23 2010-03-03 詹森药业有限公司 作为快速离解的多巴胺2受体拮抗剂的吡啶衍生物
RU2489431C2 (ru) 2007-04-23 2013-08-10 Янссен Фармацевтика Н.В. Тиа(диа)золы как быстро диссоциирующие антагонисты рецептора допамина 2
JP5417439B2 (ja) 2008-07-03 2014-02-12 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 5−ht6受容体アンタゴニストとしての置換された6−(1−ピペラジニル)−ピリダジン類
LT2307374T (lt) 2008-07-31 2017-04-25 Janssen Pharmaceutica Nv Piperazin-1-il-trifluormetil-pakeistieji piridinai kaip greitai disocijuojantys dopamino 2 receptoriaus antagonistai
CN118496638B (zh) * 2024-07-22 2024-11-22 海安浩驰科技有限公司 一种抗紫外车窗膜及其制备方法

Also Published As

Publication number Publication date
DK150478B (da) 1987-03-09
NZ181972A (en) 1978-07-28
YU233676A (en) 1983-01-21
JPS5239683A (en) 1977-03-28
FI61482B (fi) 1982-04-30
PL117323B1 (en) 1981-07-31
NO147672C (no) 1983-05-25
LU75837A1 (ref) 1977-05-04
DE2642856C2 (ref) 1990-06-21
PH12497A (en) 1979-04-05
AU1787876A (en) 1978-03-23
GB1539473A (en) 1979-01-31
PL192578A1 (pl) 1979-02-26
SE7610501L (sv) 1977-03-24
FI61482C (fi) 1982-08-10
DK150478C (da) 1987-10-05
CH628623A5 (en) 1982-03-15
FR2325377B1 (ref) 1980-04-18
IE43802B1 (en) 1981-06-03
FI762698A7 (ref) 1977-03-24
SE427839B (sv) 1983-05-09
DE2642856A1 (de) 1977-03-24
IT1073893B (it) 1985-04-17
IE43802L (en) 1977-03-23
ES451768A1 (es) 1978-05-01
GR58469B (en) 1977-10-14
YU39973B (en) 1985-06-30
AU510029B2 (en) 1980-06-05
NL187267B (nl) 1991-03-01
PT65631A (en) 1976-10-01
CA1068271A (en) 1979-12-18
ATA702976A (de) 1981-02-15
NO763054L (no) 1977-03-24
NO147672B (no) 1983-02-14
JPS6016417B2 (ja) 1985-04-25
PT65631B (en) 1978-07-05
FR2325377A1 (fr) 1977-04-22
BG27543A3 (bg) 1979-11-12
IL50522A0 (en) 1976-11-30
NL187267C (nl) 1991-08-01
DK427876A (da) 1977-03-24
AT363935B (de) 1981-09-10
SU747424A3 (ru) 1980-07-23
IL50522A (en) 1979-09-30
NL7610513A (nl) 1977-03-25
RO70079A (ro) 1982-10-26
CS222663B2 (en) 1983-07-29

Similar Documents

Publication Publication Date Title
BE837849A (fr) Alpha-aminomethyl-5-hydroxy-2-pyridinemethanols
BE843236A (fr) 11-desoxy-16-aryloxy-w-tetranorprostaglandines
HU172964B (hu) Sposob poluchenija n-aril-n-/1-l-4-piperidinil/-aril-acetamidov
ATA444276A (de) Skiroller
BE839163A (fr) Pyrimidinylurees
BE843855A (fr) L-pyroglutamyl-l-prolinamide
BE844862A (fr) Kopieerfreesmachine
BE840501A (nl) Heihamer
BE848946A (fr) Plugkraan
BE838960A (fr) Tris-phenols
BE840251A (fr) 5-phenyl-2-furamidoximes
JPS51102533A (ja) Fukusushorisochikannotsushinseigyosochi
JPS51109612A (ja) Soonboshitetsudosharin
BE844533A (fr) Azabicycloheptanes
JPS51100794A (ja) Tankasuisosokuteisochi
JPS51110982A (ja) Handotaiatsuryokuhenkanki
BE846485A (fr) Mono-methylolether-diols
BE844886R (fr) Styrylamidines
BE841186A (fr) Phenylimino-2h-quinolizines
JPS51109655A (ja) Kijuhansosochi
DK90976A (da) Stenbor
BE841474A (fr) Kraanschepbak
JPS51105454A (ja) Maruamiki
JPS51103447A (ja) Sosakogakukei
BE836633A (fr) Phenylhydrazinopyridazines

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HMM4 Cancellation of final prot. due to non-payment of fee